
Incannex Healthcare Limited (NASDAQ:IXHL) (ASX: IHL) announced that it has executed a term sheet with binding commercial terms to wholly acquire APIRx Pharmaceutical USA, LLC, subject to shareholder approval under ASX listing Rule 7.1.
The proposed acquisition is for 100% of the issued share capital in APIRx Pharmaceutical USA, LLC by Incannex Healthcare Limited from the APIRx shareholders.